Constructing a continuous-flow bioreactor with co-immobilized KmAKR and BmGDH for synthesizing tert-butyl 6-cyano-(3R,5R)-dihydroxyhexanoate

Wen Zhang,Shu-Fang Li,Jia-Qi Zhu,Hai-Xing Cao,Hua-Tao Liu,Zi-Qing Shao,Shen-Yuan Xu,Ya-Jun Wang,Yu-Guo Zheng
DOI: https://doi.org/10.1016/j.bej.2023.108964
IF: 3.9
2023-08-01
Biochemical Engineering Journal
Abstract:tert-Butyl 6-cyano-(3R,5R)-dihydroxyhexanoate ((3R,5R)-2), an important precursor of atorvastatin, can be synthesized through asymmetric reduction of tert-butyl 6-cyano-(5R)-hydroxy-3-oxohexanoate ((5R)-1) by the aldo-keto reductases (AKRs), coupled with BmGDHs for cofactor regeneration. Herein, we employed glutaraldehyde (GLA) and polyethyleneimine (PEI) resin microsphere to co-immobilize KmAKR and BmGDH. The immobilizate activity of KmAKR&BmGDH@amino resin-PEI peaked at 73 U/g, and 80.7% activity remained after 10 cycles of reuse. Continuous flow bioreactor packed with the KmAKR&BmGDH@amino resin-PEI had ∼3.7-fold higher space-time yield (STY, 374.7 g/L/d) than the batch mode. Moreover, excellent operational stability was achieved, remaining over 95% conversion after 90 h consecutive usage. Hence, a self-sustaining closed-loop bienzymatic platform running in the continuous flow mode was developed.
engineering, chemical,biotechnology & applied microbiology
What problem does this paper attempt to address?